ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,747 | -23.0% | 34,436 | +9.2% | 0.00% | – |
| Q2 2023 | $43,838 | +42.9% | 31,538 | +63.5% | 0.00% | – |
| Q1 2023 | $30,671 | -76.3% | 19,290 | -7.0% | 0.00% | – |
| Q4 2022 | $129,198 | +14.3% | 20,738 | +23.0% | 0.00% | – |
| Q3 2022 | $113,000 | +4.6% | 16,856 | -0.8% | 0.00% | – |
| Q2 2022 | $108,000 | +120.4% | 16,998 | +62.1% | 0.00% | – |
| Q1 2022 | $49,000 | -76.3% | 10,487 | +88.6% | 0.00% | – |
| Q3 2020 | $207,000 | -60.0% | 5,559 | -45.0% | 0.00% | – |
| Q2 2020 | $518,000 | +119.5% | 10,110 | +154.9% | 0.00% | – |
| Q4 2019 | $236,000 | -29.3% | 3,966 | -14.1% | 0.00% | – |
| Q1 2018 | $334,000 | +21.9% | 4,618 | +10.8% | 0.00% | – |
| Q4 2017 | $274,000 | – | 4,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |